Achieve Life Sciences (ACHV) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Achieve Life Sciences is the larger company by market cap ($751.6 million vs $6.9 million), about 109.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ACHV | VNRX |
|---|---|---|
| Share price | $7.29 | $0.2294 |
| Market cap | $751.62M | $6.90M |
| 1-day change | +0.69% | +2.98% |
| YTD return | +45.67% | — |
| 1-year return | +118.07% | — |
| 5-year return | -10.06% | — |
| EPS (TTM) | $-1.69 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.64 | $12.80 |
| 52-week low | $2.62 | $0.22 |
| Distance from 52-week high | -15.63% | -98.21% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +94.10% | — |
| Average volume | 1.44M | 8.46M |
| Shares outstanding | 103.10M | 30.06M |
| Employees | 28 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Achieve Life Sciences is about 109.0 times larger than VolitionRX by market value ($751.62M vs $6.90M).
About Achieve Life Sciences
ACHV stock →Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 28 employees
ACHV vs VNRX FAQ
Which is bigger, Achieve Life Sciences or VolitionRX?
Achieve Life Sciences (ACHV) is larger, with a market capitalization of $751.62M compared with $6.90M for VolitionRX (VNRX).
Are Achieve Life Sciences and VolitionRX in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.